Rigel Pharmaceuticals (RIGL) P/E (2010 - 2026)
Rigel Pharmaceuticals (RIGL) P/E from Jun 30, 2010 to Jul 20, 2026. The TTM Rigel Pharmaceuticals (RIGL) P/E is 84.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Rigel Pharmaceuticals (RIGL)
| Year | P/E | Change |
|---|---|---|
| 2026 | 84.44 | +204.94% |
| 2025 | 27.69 | +16.18% |
| 2024 | 23.84 | -153.64% |
| 2023 | -44.43 | +226.32% |
| 2022 | -13.62 | -37.01% |
| 2021 | -21.62 | -48.20% |
| 2020 | -41.73 | +140.37% |
| 2019 | -17.36 | +167.78% |
| 2018 | -6.48 | -40.72% |
| 2017 | -10.94 | +63.03% |
| 2016 | -6.71 | -21.45% |
| 2015 | -8.54 | +33.48% |
| 2014 | -6.40 | -20.35% |
| 2013 | -8.03 | -56.15% |
| 2012 | -18.32 | -41.55% |
| 2011 | -31.35 | -613.58% |
| 2010 | 6.10 | N/A |
Comparison Rigel Pharmaceuticals (RIGL) P/E with competitors
Rigel Pharmaceuticals (RIGL) P/E is 84.44.